Lithium Carbonate ER Tablets and Moxetumomab Pasudotox-tdfk
Determining the interaction of Lithium Carbonate ER Tablets and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Carbonate ER Tablets-Moxetumomab pasudotox-tdfk Intravenous
- Lithium Carbonate ER Tablets-Moxifloxacin
- Lithium Carbonate ER Tablets-Moxifloxacin (Systemic)
- Lithium Carbonate ER Tablets-Moxifloxacin Hydrochloride
- Lithium Carbonate ER Tablets-Moxifloxacin Injection
- Lithium Carbonate ER Tablets-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Lithium Carbonate Tablets
- Moxetumomab Pasudotox-tdfk-Lithium Citrate Syrup
- Moxetumomab Pasudotox-tdfk-Lithium Controlled-Release and Extended-Release Tablets
- Moxetumomab Pasudotox-tdfk-Lithium ER
- Moxetumomab Pasudotox-tdfk-Lithium Oral Solution
- Moxetumomab Pasudotox-tdfk-Lithium Salts